Available datapackage for study 'A Phase 3, Randomized, Open-Label Study of Nivolumab Combined With Ipilimumab Versus Sunitinib Monotherapy in Subjects With Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma'

Name: Available datapackage for study 'A Phase 3, Randomized, Open-Label Study of Nivolumab Combined With Ipilimumab Versus Sunitinib Monotherapy in Subjects With Previously Untreated, Advanced or Metastatic Renal Cell Carcinoma'
Creator: Vivli
Published: 2026-04-14 12:22:59
License: 暂无描述

DataCite Commons2026-04-14 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00011971.0

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to compare the objective response rate, progression free survival and the overall survival of Nivolumab combined with Ipilimumab to Sunitinib monotherapy in patients with previously untreated Renal Cell Cancer.

提供机构：

Vivli

创建时间：

2026-04-14